This patent teaches the use of mesenchymal stem cells for preventing allograft rejection through immune modulation.
It is known that bone marrow cells can display a veto-like effect in that they are capable of inducing donor-specific tolerance. The bone marrow cells are one source of mesenchymal stem cells. In this patent purified mesenchymal stem cells are claimed not only for inducing donor-specific tolerance but also immune modulation to third-party antigens.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.